PHILADELPHIA – Rohm and Haas today updated its expected 2007 guidance and outlook for 2008.
company expects 2007 sales of approximately $8.8 billion, with growth
in the fourth quarter of approximately 9 to 10% over the prior-year
Earnings will be adversely impacted by the price
of raw materials, which increased $60 million over the same period in
2006. The company has increased prices to cover these added raw
material costs, and expects to have new pricing in place to cover
further cost escalations by the beginning of first quarter 2008.
the full-year 2008, the company forecasts a sales increase of
approximately 14%. “Our 2008 outlook is positive,” notes Raj L. Gupta,
president and CEO.
WICHITA, KS - Aeroflex announced that it has signed Restronics as a manufacturer's representative for its automated test equipment (ATE) product line in the United States. According to Aeroflex, Restronics will provide an additional sales channel in the United States for its line of ATE equipment.
"The addition of Restronics as our manufacturer's representative provides Aeroflex with a highly skilled sales force to represent our products nationwide," said Ryan Panos, VP of Worldwide Sales, Aeroflex Test Solutions. "Adding Aeroflex to our product line fills a gap for our customers seeking high quality ATE equipment," said Ralph Savage, president, Restronics.
PETACH-TIKVA, ISRAEL – PCB manufacturer Eltek Ltd. reported third-quarter revenues of $8.8 million, up 2.3% sequentially, and down 12% year-over-year. The company incurred a third-quarter loss of $223,000, down from net income of $482,000 last year. Read more ...
PLYMOUTH, MN – Innovex received a staff deficiency letter from Nasdaq stating that for the last 30 consecutive business days, the bid price of the company’s common stock has closed below the minimum $1 per share required for continued inclusion on the Nasdaq Global Market.
Therefore, the PWB fabricator was not in compliance and has until May 19 to regain compliance.
If at anytime before May 19, the bid price of the company’s common stock closes at $1 per share or more for a minimum of 10 consecutive business days, compliance will be achieved.
The Nasdaq staff deficiency letter has no effect on the listing of the company’s common stock at this time, Innovex reports.